Get startedLog in
    Picture of China Biotech Services Holdings logo

    8037 — China Biotech Services Holdings Cashflow Statement

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapMomentum Trap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for China Biotech Services Holdings, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    C2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    HKAS
    HKAS
    HKAS
    HKAS
    HKAS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line203181863-142-253
    Depreciation
    Amortisation
    Non-Cash Items717.2-11.330.3129
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital172-225-435248-49.5
    Change in Accounts Receivable
    Change in Inventories
    Change in Payable / Accrued Expenses
    Other Operating Cash Flow
    Cash from Operating Activities42240.5483192-152
    Capital Expenditures-127-12.2-122-59.4-51.7
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items0.3524.09-1354.993.88
    Acquisition of Business
    Sale of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-126-8.12-256-54.4-47.8
    Financing Cash Flow Items-3.79-219-303-16276
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities43.9-267-282-156148
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash339-234-57.8-20.7-53.2